Work

A phase II study of capecitabine-oxaliplatin and cetuximab in patients (pts) with advanced/metastatic gastric cancer (G) or gastroesophageal junction (GEJ) adenocarcinoma.

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.15_suppl.4096

Authors: Syma Iqbal, Anthony B. El-Khoueiry, Dongyun Yang, David Páez, Vinay Duddalwar, Wu Zhang, Raluca Dana Agafitei, Ramona Lujan, Sarah Cole, Yan Ning, Rita El-Khoueiry, Fotios Loupakis, Takeru Wakatsuki, Heinz-Josef Lenz

Institution: USC Norris Comprehensive Cancer Center

Language: English

Topic: Gastric Cancer Management and Outcomes

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W30712822

Cites:

Cited by:

Related to: 10